Stifel lowered the firm’s price target on Monster Beverage to $63 from $65 and keeps a Buy rating on the shares. The firm reduced its 2024-2025 sales and EPS estimates “slightly,” mainly reflecting weakening U.S. sales growth, but said it remains comfortable with its above-consensus Q1 sales expectations and thinks “a less-bad-than-feared result,” including a solid month of April sales, could potentially be a positive catalyst for shares given weak investor sentiment.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNST:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Monster Beverage to Report Financial Results for 2024 First Quarter on May 2, 2024
- Monster downgraded, Five Below upgraded: Wall Street’s top analyst calls
- Monster Beverage double downgraded to Sell at Truist
- Monster Beverage downgraded to Sell from Buy at Truist
